Drug Shortage Report for MYLAN-TADALAFIL
| Report ID | 207187 |
| Drug Identification Number | 02410664 |
| Brand name | MYLAN-TADALAFIL |
| Common or Proper name | TADALAFIL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 4BL |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-09-26 |
| Estimated end date | 2023-12-12 |
| Actual end date | 2023-12-11 |
| Shortage status | Resolved |
| Updated date | 2023-12-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-12-19 | French | Compare |
| v5 | 2023-12-19 | English | Compare |
| v4 | 2023-11-28 | French | Compare |
| v3 | 2023-11-28 | English | Compare |
| v2 | 2023-10-17 | French | Compare |
| v1 | 2023-10-17 | English | Compare |
Showing 1 to 6 of 6